PubMed

Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects.

Chatterjee K, Ports TA, Brundage BH, Massie B, Holly AN, Parmley WW.

Ann Intern Med. 1980 May;92(5):600-4.PMID: 7386999 [PubMed - indexed for MEDLINE]Related articles

Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.

Elkayam U, Weber L, McKay CR, Rahimtoola SH.

Am J Cardiol. 1984 Jul 1;54(1):126-31.PMID: 6741802 [PubMed - indexed for MEDLINE]Related articles

Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.

Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.

Pediatrics. 2006 Jul;118(1):e76-84. Epub 2006 Jun 2.PMID: 16751617 [PubMed - indexed for MEDLINE]Related articlesFree article

Oral hydralazine therapy for chronic refractory heart failure.

Chatterjee K, Parmley WW, Massie B, Greenberg B, Werner J, Klausner S, Norman A.

Circulation. 1976 Dec;54(6):879-83.PMID: 825327 [PubMed - indexed for MEDLINE]Related articles

Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.

Cavero PG, De Marco T, Kwasman M, Lau D, Liu M, Chatterjee K.

J Am Coll Cardiol. 1992 Dec;20(7):1542-8.PMID: 1452928 [PubMed - indexed for MEDLINE]Related articles

Acute hemodynamic effects of endralazine: a new vasodilator for chronic refractory congestive heart failure.

Quyyumi AA, Wagstaff D, Evans TR.

Am J Cardiol. 1983 May 1;51(8):1353-7.PMID: 6846162 [PubMed - indexed for MEDLINE]Related articles

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.

Ader R, Chatterjee K, Ports T, Brundage B, Hiramatsu B, Parmley W.

Circulation. 1980 May;61(5):931-7.PMID: 6244906 [PubMed - indexed for MEDLINE]Related articles

Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.

Massie B, Chatterjee K, Werner J, Greenberg B, Hart R, Parmley WW.

Am J Cardiol. 1977 Nov;40(5):794-801.PMID: 411364 [PubMed - indexed for MEDLINE]Related articles

Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.

Rubin SA, Chatterjee K, Ports TA, Gelberg HJ, Brundage BH, Parmley WW.

Am J Cardiol. 1979 Nov;44(6):1183-9.PMID: 495513 [PubMed - indexed for MEDLINE]Related articles

Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.

Kereiakes D, Chatterjee K, Parmley WW, Atherton B, Curran D, Kereiakes A, Spangenberg R.

J Am Coll Cardiol. 1984 Nov;4(5):884-9.PMID: 6238076 [PubMed - indexed for MEDLINE]Related articles

Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.

Chatterjee K, Ports TA, Arnold S, Brundage B, Parmley W.

Br Heart J. 1979 Dec;42(6):657-63.PMID: 534582 [PubMed - indexed for MEDLINE]Related articlesFree article

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.

Franciosa JA, Pierpont G, Cohn JN.

Ann Intern Med. 1977 Apr;86(4):388-93.PMID: 848799 [PubMed - indexed for MEDLINE]Related articles

Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.

Massie BM, Packer M, Hanlon JT, Combs DT.

J Am Coll Cardiol. 1983 Aug;2(2):338-44.PMID: 6345633 [PubMed - indexed for MEDLINE]Related articles

Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.

Kukin ML, Freudenberger RS, Mannino MM, Kalman J, Steinmetz M, Buchholz-Varley C, Ocampo ON.

Am Heart J. 1999 Aug;138(2 Pt 1):261-8.PMID: 10426837 [PubMed - indexed for MEDLINE]Related articles

Hemodynamic effects of alpha1-adrenoceptor antagonist, doxazosin, in patients with chronic congestive heart failure.

Kieback AG, Rödiger O, Jaenecke H, Grohmann A, Wernecke KD, Baumann G, Felix SB.

J Cardiovasc Pharmacol. 2005 Oct;46(4):399-404.PMID: 16160589 [PubMed - indexed for MEDLINE]Related articles

Hydralazine in chronic CHF.

Chatterjee K, Rouleau JL, Massie BM.

Acta Med Scand Suppl. 1981;652:99-113.PMID: 6949469 [PubMed - indexed for MEDLINE]Related articles

Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.

Nelson GI, Silke B, Forsyth DR, Verma SP, Hussain M, Taylor SH.

Am J Cardiol. 1983 Nov 1;52(8):1036-40.PMID: 6637819 [PubMed - indexed for MEDLINE]Related articles

The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.

Rubin LJ, Handel F, Peter RH.

Circulation. 1982 Jun;65(7):1369-73.PMID: 7074795 [PubMed - indexed for MEDLINE]Related articles

Attenuation of prazosin effect on cardiac output in chronic heart failure.

Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K.

Ann Intern Med. 1979 Sep;91(3):345-9.PMID: 475164 [PubMed - indexed for MEDLINE]Related articles

Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure.

Ginks WR, Redwood DR.

Br Heart J. 1980 Sep;44(3):259-64.PMID: 7426183 [PubMed - indexed for MEDLINE]Related articlesFree article